Merck
CN
高级检索
Chemical Structure Search
Search Within
文件类型

112-90-3

应用筛选条件
关键词:'112-90-3'
显示 1-30 共 331 条结果 关于 "112-90-3" 范围 技术文档
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
105 70 110 66 84 111 1:16 dil 129 84 42 108 87 90 94 61 83 100 64 114 61 75 116 Average 121 84 49 107 95 93 94 66 87 104 69 110 68 83
The Effective Use of Protein Kinase Inhibitors
104 71 50 3 4 13 3 95 78 38 65 34 91 93 96 66 39 93 79 94 103 69 109 20 105 86 90 3 3 96 89 71 93 76 94 96 7
Separation of alanine oligomeres
Separation of alanine oligomeres TLC Application Note 112 Merck Millipore is a division of Merck KGaA, Darmstadt, Germany www.merckmillipore.com/chromatography
Verfication summary-03-0202-00
2822621 3 MRD (1:2) 56.40 1.0 2% 112.80 1.0 1% - 3 1:4 31.71 1.1 3% 126.84 1.1 1% 112% 3 1:8 15.82 1.0 6% 126.59 1.0 1% 112% 3 1:16 8.04 0.1 2% 128.61 0.1 0% 114%
Verfication summary-03-0202-00
2822621 3 MRD (1:2) 56.40 1.0 2% 112.80 1.0 1% - 3 1:4 31.71 1.1 3% 126.84 1.1 1% 112% 3 1:8 15.82 1.0 6% 126.59 1.0 1% 112% 3 1:16 8.04 0.1 2% 128.61 0.1 0% 114%
NovAseptic Valve: Valve Body, Tank Outlet Valve 90°, Elbow 90° TC, Part No: NU###/441-312
3.583) NU300 3" 76.2x1.65 (3.0x0.065) NovAseptic® Valve Valve Body, Tank Outlet Valve 90˚, Elbow 90˚ TC Catalogue Number NU###/441-312 Valve Body, Tank Outlet Valve 90˚, Elbow 90˚ TC Configuration
Quality Control Ranges: MILLIPLEX® MAP Human Cytokine/ Chemokine Magnetic Bead Panel
Control 1 112 – 232 pg/mL IL-9 Control 1 111 – 231 pg/mL Control 2 559 – 1161 pg/mL Control 2 533 – 1107 pg/mL
Product Information Sheet - T6791
Oxford / Chichester, UK), Chapter 4, Section 1, pp. 89-90 (2014). 6. Wanders, R.J.A. et al., J. Inherit. Metab. Dis., 18(Suppl. 1), 101-112 (1995). Trizma is a registered trademark of Sigma-
The Effective Use of Protein Kinase Inhibitors
104 71 50 3 4 13 3 95 78 38 65 34 91 93 96 66 39 93 79 94 103 69 109 20 105 86 90 3 3 96 89 71 93 76 94 96 7
NovAseptic Valve: Valve Body, Tank Outlet Valve 180°, Elbow 90°, Part No: NU###/451-311
0.394) NU300 3" 76.2x1.65 (3.0x0.065) NovAseptic® Valve Valve Body, Tank Outlet Valve 180˚, Elbow 90˚ Catalogue Number NU###/451-311 Valve Body, Tank Outlet Valve 180˚, Elbow 90˚ Configuration
NovAseptic Valve: Valve Body, Shut off 90° TC, Part No: NA##/31-212 and NU###/31-212
) NA76 76.2x1.65 NU300 3" 76.2x1.65 (3.0x0.065) NovAseptic® Valve Valve Body, Shut off 90˚ TC Catalogue Number NA##/31-212 and NU###/31-212 Valve Body, Shut off 90˚ TC Configuration Specification
NovAseptic Valve: Valve Body, Tank Outlet Valve 180°, Elbow 90° TC, Part No: NU###/451-312
20µin) External surface Ra ≤ 1.6µm (63µin) Design Temperature, Valve Body: -80 to 200 ºC (-112 to 392 ºF) Design Pressure, Valve Body: -1 to 10 bar(g) (-14.5
NovAseptic Valve: Valve Body, Tank Outlet Valve 90°, Elbow 90°, Part No: NU###/441-311
(15 μin) External surface Ra ≤ 1.6 μm (63 μin) Design Temperature, Valve Body –80 to 200 ºC (–112 to 392 ºF) Design Pressure, Valve Body –1.03 to 10 bar(g) (–15 to 145 psi(g)) Note The
Data Sheet - C9774 - Lot 076K8807
requirements Pass Specific rotation, [α]D25 5 mg/ml solution in alcohol between +105° and +112° +108° Assay  high pressure liquid chromatography not less than 97.0% and not more than
Data Sheet - R8157 - Lot 109K0794
mM NaCl, 0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼112 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 459–621 nmole/min/mg (see Figure
Data Sheet - M8698
sulfoxide reductase restores ability to activate the plasma membrane Ca-ATPase. Biochemistry, 38, 105–112 (1999). 5. Davis, D.A., et al., HIV-2 protease is inactivated after oxidation at the dimer interface
Product Information Sheet - C2882
formula:C27H48O Molecular weight: 388.67 [α]D (C = 1 in chloroform): 29.5-32.5° Melting point: 108-112 °C 5β-Cholestan-3α-ol (epicoprostanol) belongs to the family of sterols with saturated side chains
Data Sheet - H157
receptor antagonist, HOE 140, in isolated blood vessels from different species. Br. J. Pharmacol., 112, 683-689 (1994). Wirth, K., et al., Hoe 140, a new potent and long acting bradykinin antagonist:
NovAseptic®Mixer: Tank Plate, GMP ATEX Specification
1.50) — 18 (0.71) 44 (1.73) M6 45º 50 (1.97) — 3 (0.12) 1 (0.04) 2.5 (0.10) GMP50 ATEX AX1/33 54 (2.13) 90 (3.54) 58 (2.28) 50 (1.97)
NovAseptic Valve: Valve Body, Shut off 90°, TC connectable, Part No: NA##/371-211 and NU###/371-211
240µ-in] External surface Ra [ 1,6µm [63µ-in] Design Temperature, Valve Body: -80°C to 200°C [-112°F to 392°F] Design Pressure, Valve Body: -1 to 10 bar(g) [-14.5psi to 101.5psi] Note!
Data Sheet - SAE0022
different genes. In most cell types the PGM1 isozyme is predominant, representing about 90% of total PGM activity.3 Native PGM1 is known to be post- translationally modified by cytoplasmic glycosylation
Data Sheet - V3639
trichlorocarbanilide in control of the protonmotive force in Escherichia coli cells. Biochem. J., 212, 105-112 (1983). 5. Davidson, G.A., and Berma, M.C., Interaction of valinomycin and monovalent cations with
D-Tubes and U-Tubes Profiler
6-8 kDa 3–10 ml 3–10 ml 3–10 ml 3–10 ml 10 tubes 50 tubes 10 tubes 50 tubes 71739-3 71739-4 71740-3 71740-4 84 338 84
NovAseptic Valve: Valve Body, Shut off 90°, TC connectable, Part No: NU###/4710-221
μin) External surface Ra ≤ 1.6 μm (63 μin) Design Temperature, Valve Body –80 to 200 ºC (–112 to 392 ºF) Design Pressure, Valve Body –1 to 10 bar(g) (–14.5 to 145 psi(g))
Cinalukast (Ro 24-5913)- subtype selective orally active cysteinyl leukotriene (CysLT1) receptor antagonist
al., Clin. Exp. Allergy, 33, 1380-1388 (2003). 2. Kawano, T., J. Allergy Clin. Immunol., 112, 369-374 (2003). 3. Hui, Y. and Funk, C.D., Biochem. Pharmacol., 64, 1549-1157 (2002). 4. O’Donnell, M., et
Data Sheet - R8157
NaCl, 0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: 112 kDa Precautions and Disclaimer This product is for R&D use only, not for drug, household, or
NovAseptic®Mixer, Tank Plate, GMP and HS
— 18 (0.71) 44 (1.73) M6 45º 50 (1.97) — 3 (0.12) 1 (0.04) 2.5 (0.10) GMP 50, HS T10 & USM T10 GM1/33 54 (2.13) 90 (3.54) 58
Data Sheet - A1858 - Lot 029K0696
glycerol. Molecular mass: ∼60 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 82–112 nmole/min/mg (see Figure 2) Precautions and Disclaimer This product is for R&D use only, not for
Data Sheet - A1858 - Lot 010M0846
glycerol. Molecular mass: ∼60 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 82–112 nmole/min/mg (see Figure 2) Precautions and Disclaimer This product is for R&D use only, not for
Data Sheet - SAB4200155
15, 607-660 (1999). 2. Cook, A., et al., Annu. Rev. Biochem., 76, 647-671 (2007). 3. Weis, K., Cell, 112, 441-451 (2003). 4. Jakel, S., et al., EMBO J., 21, 377- 386 (2002). 5. Deng, D., et al.
1/12